This text is a result of machine translation.
Muyuan shares: it is expected that the pig price in the second half of the year is higher than that in the first half of the year, and the company's liquidity will continue to improve
Exclusive Interview with Song Xiangqian, Founding Partner and Chairman of Harvest Capital
Harvest Capital invests in key fast-growing sectors dominated by large-sized players. Its portfolio includes snack giants Qiaqia Food (002557) (Chinese: 洽洽食品) and LYFEN (Chinese: 来伊份), energy drink startup Eastroc Beverage (605499) (Chinese: 东鹏饮料), Chinese fast-food chain Home Original Chicken (Chinese: 老乡鸡), top on-demand local delivery and retail platform Meituan Dianping (03690) (Chinese: 美团点评) and Chinese ride-sharing behemoth Didi (DIDI: NYSE) (Chinese: 滴滴出行).
Yesterday 02:14 PM
Research
Consumer StaplesChina’s Food and Beverage Industry in Search of Methods to Shrink its Carbon Footprints
Hang Seng Introduces Metaverse, Genomics, and Oncology Indexes
On May 23rd, Hang Seng Indexes Company Launches Hang Seng China Metaverse Index and the Hang Seng Shanghai-Shenzhen-Hong Kong Genomics and Oncology Index. These two indexes are created to capture the performance of companies that deal with Metaverse, Genomics, and Oncology concepts, which have become increasingly popular among investors.
Yesterday 04:54 PM
Ophthalmological Medtech Startup Raises Tens of Mns of CNY in Series C Funding
Founded in 2011, Suzhou Microclear Medical is engaged in the ophthalmology and optometry imaging field. Microclear integrates self-developed components with artificial intelligence technology to provide high-quality devices and services for hospitals and basic medical institutes across the world.
Yesterday 04:18 PM
Muyuan shares: the "general salary reduction of 10% - 40%" of Netcom is false information
Yulin City, Shaanxi province carried out a special survey on public opinion of coal price information
Electrophysiology AccuPulse Raises Nearly CNY 100 Million in Series A Funding
Founded in November 2020, Suzhou AccuPulse is committed to becoming an international leading platform-based innovative cardiac electrophysiology company. The company has established a research and development team led by well-known electrophysiological experts in the US with R&D centers in Suzhou and in the United States.
May 20, 2022 05:17 PM
Pork stocks weakened in shock
Xinwangda: grant 8.234 million restricted shares and 16.67 million stock options to incentive objects
The main force continued to increase its position in lithium battery stocks in the late trading, and sold off banks and pharmaceutical stocks
Exclusive Interview with Liu Di, Managing Director of Peakview Capital
May 21, 2022 12:51 PM